Two lung cancer risk variants in the TERT region (rs401681, OR per allele C = 0.89 (0.82–0.96), p = 0.0037; rs4975616, OR per allele A = 0.90 (0.83–0.97), p = 0.010), as well as the prostate cancer risk variant (rs7679673 in TET2; OR per allele C = 0.89 (0.82–0.97), p = 0.0057), were associated with a decreased risk of overall NHL. The gene discussed is TERT; the disease is non-Hodgkin lymphoma.